Background: Radical prostatectomy (RP) is one of the curative treatment options for patients with prostate cancer to achieve long-term survival, but it is accompanied by potential complications. The Martin criteria used as a format for reporting complications has become standard in recent years. However, it has not been applied in RP in Asian countries. In the present study, we investigated the early complications of RP developing within 90 days in our institute according to the Martin criteria. Methods: Between January 2003 and November 2011, patients with organ-confined adenocarcinoma of the prostate who received RP in our institute were retrospectively reviewed. The operation was done as open RP, or minimally invasive RP, including laparoscopic RP and robotassisted laparoscopic RP (RaLP). The preoperative, operative, postoperative, and pathological parameters were recorded for analysis. Definitions of complications were adopted from previous reports. Surgical and medical complications developed within 90 days postoperatively were identified respectively; severity of each complication was classified according to ClavieneDindo classification. ClavieneDindo classification grade III or higher complications were viewed as major complications. Results: A total of 359 patients were included; 280 (78%) underwent open RP, 45 (12.5%) received laparoscopic RP, and 34 (9.5%) had RaLP. The overall complication rate was 40.1%, and the major complication rate was 13.1%. There was no surgical mortality. Diarrhea requiring conservative treatment (13.6%), minor urine leakage (9.5%), and gout attack (4.2%) were the leading complications. Minimally invasive RP had higher rates of lymph leakage (p ¼ 0.015) and upper-extremity neuropathy (p ¼ 0.048). Body mass index >25 kg/m 2 and use of neoadjuvant hormone therapy were predictors for overall and major complications, whereas diabetes mellitus also predicted the development of major complications. Besides lower case volume and learning curve for RaLP, patients' higher age at surgery and higher risk for disease progression compared to the Western series may be responsible for the higher complication rates. Conclusion: The early complication rates of RP in our patients were slightly high compared to the Western series. By standardized report, being overweight, diabetes mellitus, and use of neoadjuvant hormone therapy were identified as predictors of early complications in our series.
Introduction
Prostate cancer is one of the leading malignant neoplasms among male Taiwanese. Treatment should be tailored individually based on the risk of disease progression, life expectancy at diagnosis, and possible complications of each treatment modality, as well as the patient's preference and expected compliance. As the screening test with serum 3 proposed the "Martin criteria" to evaluate the quality of operative complication reports, and the criteria have become the standard format in many surgical fields, including urology. To our knowledge, there are no such standardized complication reports concerning RP in Asian people. In the present study, we retrospectively reviewed complications developing within 90 days after RP in our institute and reported them using the Martin criteria.
Methods
The preoperative, operative, and postoperative parameters of patients with organ-confined adenocarcinoma of the prostate receiving RP by any of 10 attending urologists in our institute between January 1, 2003 and November 30, 2011 were retrospectively reviewed. The pathological details were also recorded. The low, intermediate, or high risk for disease progression was defined according to the National Comprehensive Cancer Network Guideline in Prostate Cancer Version 3 2010. 4 The operation could be open RP (ORP) or minimally invasive RP (MIRP), including laparoscopic RP (LRP) and robot-assisted laparoscopic RP (RaLP, which was launched in our institute in December 2009). Standards from the Martin criteria modified by Donat et al 5 for urological oncologic surgery were used in this study. Surgical and medical complications developing within 90 days postoperatively were included as early complications. They were divided into eight fields: including wound, urology, hematology, neuromuscular disorder, nephrology, gastroenterology, cardiology, and dermatology. Definitions of complications were adapted from other RP complication reports, 6e9 and graded according to the ClavieneDindo classification. 10 The definitions of complications are shown in Table 1 
Results
During the study period, a total of 363 consecutive patients underwent RP in our institute. Four patients were excluded because of rare histology (3 sarcoma and 1 basal cell carcinoma). Median age at surgery was 67 years; median preoperative PSA was 9.37 ng/mL; 280 patients (78%) received ORP, and 45 patients (12.5%) underwent LRP; RaLP was done in 34 patients (9.5%). Because of similar physiological change during operation and similar stage with regard to the learning curve, we combined LRP and RaLP as MIRP for further analysis. Other demographic data are shown in Table 2 .
Patients receiving MIRP were older (p < 0.001), and, although operation time was longer in the MIRP group (p < 0.001), the amount of intraoperative blood loss (p < 0.001) and intraoperative blood transfusion rate (p < 0.001) were significantly lower than those in the ORP group. However, more lymph nodes could be obtained during ORP (p < 0.001), and there was a lower positive surgical margin rate (p < 0.001). Duration for the postoperative urethral catheterization was longer in the ORP group (p < 0.001), but duration for the retention of drainage catheter was shorter (p < 0.009). Postoperative follow-up was also shorter in the MIRP group (p < 0.001). There was no statistical difference between the two groups concerning other patient characteristics.
The detailed complications of RP are listed in Table 3 . The overall early complication rate was 40.1%, whereas the major complication rate was 13.1% [including major surgical complications (12%) and major medical complications (1.1%)]. There was no surgical mortality in our series. Diarrhea under conservative treatment was the most common complication (13.6%), followed by minor anastomotic leakage (9.5%) and gout attack (4.2%). Compared to ORP, the MIRP group had higher rates of lymph leakage (6.3%, p ¼ 0.015) and upperextremity neuropathy (2.5%, p ¼ 0.048). complications, no risk factors could be identified by univariate analysis in the present study.
We compare the complications of ORP and MIRP of our series to those of other Western standardized reports in Table  5 9,11 and Table 6 , 6,7,9,11e13 respectively. Overall complication rate of ORP (39.3%) was comparable to that in other series, but there was a higher major complication rate in our study (14.6%). By contrast, our MIRP series had higher overall (43%) and major complication rates (7.6%) than did the pure RaLP series, but were comparable to those of pure LRP reports.
Discussion
Complications of surgery, which may vary in different countries, are key information for patients in making informed decisions. Well-documented complication reports have been published in Western countries, but a comprehensive report concerning RP is not yet available in Taiwan. Patients with prostate cancer in Taiwan might not be able to undergo RP by their own choice, which may potentially damage the patientephysician relationship. Moreover, communication and comparison among different complication reports could improve the understanding of specific surgeries and hence, prevent the development of complications. However, patient selection, tumor selection, and surgical experience, as well as assessment tools, definitions, and the time at which the evaluation is performed, will influence the presentation of postoperative outcome. The Martin criteria provides a standardized system to ensure consistency and clarity in reporting. A true comparison across different series or surgical approaches may be possible in such situations, 3 but it may be expensive and time-consuming to analyze and present the complications fulfilling the Martin criteria. Lack of consensus on complication definitions is also an issue. This awaits development by professional societies focused on particular diseases and surgical approaches. As the severity grading system depends on the intervention to manage a complication, clinically significant functional complications may be missed. Moreover, interobserver variability due to the subjective nature of the grading system may exist. 14 The Martin criteria has become the mainstay in Europe and in the USA, but to our knowledge, the present study is the first standardized report of complications of RP in an Asian country. Both overall and major complication rates of the three surgical treatment approaches in our institute were higher, especially that for MIRP. A smaller case number and learning curve may influence the development of complications. 15, 16 A higher risk for disease progression, presenting as higher serum PSA, higher clinical stage, and higher biopsy Gleason score, as well as older age in our patient group compared to other series, may also help explain the higher complication rates.
Being overweight (BMI > 25 kg/m 2 ), the presence of comorbidity of diabetes mellitus, and use of neoadjuvant hormone therapy were predictors of overall and major complications in our patients. This finding is similar to the findings from the Memorial Sloan Kettering Cancer Center; Rabbani et al 9 suggested that greater BMI, Charlson comorbidities score (especially diabetes mellitus), neoadjuvant hormone therapy, ethnicity, larger prostate size, higher biopsy Gleason score, ORP, and greater estimated blood loss, are predictors for the development of complications. Patients with diabetes mellitus are more at risk of poor wound healing, respiratory infection, myocardial infarction, and increased length of hospital stay when undergoing cardiac and noncardiac surgeries. 17 However, in other series, obese patients had prolonged operation time and increased estimated blood loss, especially during the learning curve, but failed to show association with higher complication rates.
18e21 Similarly, because of increased surgical difficulty, prolonged operation time and increased estimated blood loss were also observed in patients who received neoadjuvant hormone therapy, but there was no significant difference when it came to complication rates. 22 The current consensus is that no neoadjuvant hormonal therapy should be given because it has no obvious benefit in disease control whereas it may adversely affect surgical outcome; 23, 24 furthermore, in our experience, it may confer a higher surgical complication rate of RP.
There were several limitations of the present study. First, this was a retrospective analysis, and hence minor complications might not be described as precisely as in prospective studies. Second, the study was based on a single center, which may not be representative of the whole nation's experience. Third, all the surgeries were not done by a single urologist, and differences in surgical skill and experience may also have confounded the analysis of complications.
In conclusion, by standardized report, the early complication rates of RP in our patients were slightly higher compared to Western series. Higher patient age and higher risk for disease progression may be important to this difference. BMI > 25 kg/m 2 , diabetes mellitus, and use of neoadjuvant hormone therapy were predictors of development of early complications in our series. 
